Cargando…

CDX2 immunostaining in primary and metastatic germ cell tumours of the testis

OBJECTIVE: To evaluate the immunohistochemical staining pattern of caudal type homeobox 2 (CDX2) protein in germ cell tumours (GCTs) of the testis. METHODS: This study reassessed archival tissue samples collected from patients diagnosed with primary and metastatic testicular GCTs for CDX2 immunoreac...

Descripción completa

Detalles Bibliográficos
Autores principales: Oz Atalay, Fatma, Aytac Vuruskan, Berna, Vuruskan, Hakan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536750/
https://www.ncbi.nlm.nih.gov/pubmed/28322096
http://dx.doi.org/10.1177/0300060516665472
_version_ 1783254077548789760
author Oz Atalay, Fatma
Aytac Vuruskan, Berna
Vuruskan, Hakan
author_facet Oz Atalay, Fatma
Aytac Vuruskan, Berna
Vuruskan, Hakan
author_sort Oz Atalay, Fatma
collection PubMed
description OBJECTIVE: To evaluate the immunohistochemical staining pattern of caudal type homeobox 2 (CDX2) protein in germ cell tumours (GCTs) of the testis. METHODS: This study reassessed archival tissue samples collected from patients diagnosed with primary and metastatic testicular GCTs for CDX2 immunoreactivity using standard immunohistochemical techniques. Positive nuclear immunostaining was evaluated with regard to both the staining intensity and the extent of the staining. RESULTS: Tissue sections from primary and metastatic testicular GCTs (n = 104), germ cell neoplasia in situ (GCNis) (n = 5) and benign testicles (n = 15) were analysed. The GCNis and benign testicular tissues showed no immunoreactivity for CDX2. Strong and diffuse staining of CDX2 was demonstrated only in the mature colonic epithelium of teratomas in both primary and metastatic GCTs. CDX2 positivity in other tumours (one pure yolk sac tumour, one yolk sac component of a mixed GCT and one pure seminoma) was infrequent, and was only weak and focal. CONCLUSIONS: CDX2 immunostaining should be interpreted based on both the staining intensity and the extent of staining so as not to cause misdiagnosis. Teratomas with colonic-type epithelium should be considered in the differential diagnosis if a metastatic tumour with an unknown primary shows prominent CDX2 immunostaining.
format Online
Article
Text
id pubmed-5536750
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-55367502017-10-03 CDX2 immunostaining in primary and metastatic germ cell tumours of the testis Oz Atalay, Fatma Aytac Vuruskan, Berna Vuruskan, Hakan J Int Med Res Research Reports OBJECTIVE: To evaluate the immunohistochemical staining pattern of caudal type homeobox 2 (CDX2) protein in germ cell tumours (GCTs) of the testis. METHODS: This study reassessed archival tissue samples collected from patients diagnosed with primary and metastatic testicular GCTs for CDX2 immunoreactivity using standard immunohistochemical techniques. Positive nuclear immunostaining was evaluated with regard to both the staining intensity and the extent of the staining. RESULTS: Tissue sections from primary and metastatic testicular GCTs (n = 104), germ cell neoplasia in situ (GCNis) (n = 5) and benign testicles (n = 15) were analysed. The GCNis and benign testicular tissues showed no immunoreactivity for CDX2. Strong and diffuse staining of CDX2 was demonstrated only in the mature colonic epithelium of teratomas in both primary and metastatic GCTs. CDX2 positivity in other tumours (one pure yolk sac tumour, one yolk sac component of a mixed GCT and one pure seminoma) was infrequent, and was only weak and focal. CONCLUSIONS: CDX2 immunostaining should be interpreted based on both the staining intensity and the extent of staining so as not to cause misdiagnosis. Teratomas with colonic-type epithelium should be considered in the differential diagnosis if a metastatic tumour with an unknown primary shows prominent CDX2 immunostaining. SAGE Publications 2016-11-07 2016-12 /pmc/articles/PMC5536750/ /pubmed/28322096 http://dx.doi.org/10.1177/0300060516665472 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Reports
Oz Atalay, Fatma
Aytac Vuruskan, Berna
Vuruskan, Hakan
CDX2 immunostaining in primary and metastatic germ cell tumours of the testis
title CDX2 immunostaining in primary and metastatic germ cell tumours of the testis
title_full CDX2 immunostaining in primary and metastatic germ cell tumours of the testis
title_fullStr CDX2 immunostaining in primary and metastatic germ cell tumours of the testis
title_full_unstemmed CDX2 immunostaining in primary and metastatic germ cell tumours of the testis
title_short CDX2 immunostaining in primary and metastatic germ cell tumours of the testis
title_sort cdx2 immunostaining in primary and metastatic germ cell tumours of the testis
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536750/
https://www.ncbi.nlm.nih.gov/pubmed/28322096
http://dx.doi.org/10.1177/0300060516665472
work_keys_str_mv AT ozatalayfatma cdx2immunostaininginprimaryandmetastaticgermcelltumoursofthetestis
AT aytacvuruskanberna cdx2immunostaininginprimaryandmetastaticgermcelltumoursofthetestis
AT vuruskanhakan cdx2immunostaininginprimaryandmetastaticgermcelltumoursofthetestis